Genesco (NYSE:GCO – Get Free Report) is anticipated to post its Q2 2027 results before the market opens on Thursday, September 3rd. Analysts expect the company to post earnings of ($1.34) per share and revenue of $527.26 million for the quarter. Interested persons may review the information on the company’s upcoming Q2 2027 earning report for the latest details on the call scheduled for Thursday, September 3, 2026 at 8:30 AM ET.
Genesco Stock Down 2.9%
Genesco stock opened at $32.49 on Wednesday. The company’s 50 day simple moving average is $35.53 and its 200 day simple moving average is $33.26. Genesco has a fifty-two week low of $21.92 and a fifty-two week high of $43.60. The firm has a market capitalization of $360.96 million, a price-to-earnings ratio of 18.78 and a beta of 1.80. The company has a debt-to-equity ratio of 0.08, a current ratio of 1.83 and a quick ratio of 0.37.
Analysts Set New Price Targets
Several equities research analysts have weighed in on GCO shares. Truist Financial set a $40.00 target price on shares of Genesco in a report on Friday, May 29th. Seaport Research Partners lowered shares of Genesco from a “buy” rating to a “neutral” rating in a report on Wednesday, May 27th. Weiss Ratings cut shares of Genesco from a “hold (c)” rating to a “sell (d+)” rating in a research report on Friday, June 12th. Zacks Research downgraded Genesco from a “strong-buy” rating to a “hold” rating in a research note on Friday, July 31st. Finally, Wall Street Zen lowered Genesco from a “buy” rating to a “hold” rating in a report on Saturday, June 13th. One analyst has rated the stock with a Strong Buy rating, three have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, Genesco has an average rating of “Hold” and an average price target of $36.67.
Insider Buying and Selling
In related news, Director Gregory A. Sandfort bought 2,958 shares of the company’s stock in a transaction on Thursday, July 9th. The shares were purchased at an average cost of $33.80 per share, for a total transaction of $99,980.40. Following the acquisition, the director owned 29,172 shares of the company’s stock, valued at approximately $986,013.60. This represents a 11.28% increase in their position. The purchase was disclosed in a filing with the SEC, which can be accessed through this link. Company insiders own 23.11% of the company’s stock.
Institutional Investors Weigh In On Genesco
Several large investors have recently made changes to their positions in the stock. Jones Financial Companies Lllp bought a new stake in Genesco in the 1st quarter valued at $26,000. Group One Trading LLC acquired a new position in Genesco in the 4th quarter worth $26,000. Meeder Asset Management Inc. bought a new position in Genesco during the 4th quarter worth about $37,000. Quarry LP increased its holdings in Genesco by 182.2% during the 3rd quarter. Quarry LP now owns 1,964 shares of the company’s stock worth $57,000 after purchasing an additional 1,268 shares in the last quarter. Finally, BNP Paribas Financial Markets increased its holdings in Genesco by 92.3% during the 3rd quarter. BNP Paribas Financial Markets now owns 1,960 shares of the company’s stock worth $57,000 after purchasing an additional 941 shares in the last quarter. Institutional investors own 94.51% of the company’s stock.
Genesco Company Profile
Genesco Inc is a Nashville, Tennessee-based retailer, wholesaler and licensee specializing in branded footwear, headwear, apparel and accessories. Through its portfolio of retail chains, wholesale distribution channels and licensing agreements, Genesco brings a range of product offerings to consumers in North America and Europe.
The company’s retail segment includes specialty chains such as Journeys, which targets fashion-focused teens and young adults in the United States and Canada, and Schuh, a footwear retailer with locations in the United Kingdom and Ireland.
Featured Stories
- Five stocks we like better than Genesco
- Dutch Bros Sell-Off Creates a Growth Opportunity
- NVIDIA’s MediaTek Bet Shows How It Plans to Defend Its AI Moat
- Is Abercrombie & Fitch’s Hot Streak Just Getting Started?
- Medtronic’s Stars Are Aligning for a Price Recovery
Receive News & Ratings for Genesco Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genesco and related companies with MarketBeat.com's FREE daily email newsletter.
